Home UPDATE 1-Bayer to seek approval for haemophilia drug this month
 

Keywords :   


UPDATE 1-Bayer to seek approval for haemophilia drug this month

2014-12-03 03:55:36| Chemicals - Topix.net

Drugmaker Bayer AG said on Tuesday it will this month file for approval of its experimental haemophilia drug Bay 81-8973, based on its established Kogenate brand, as it seeks to build a range of treatments against the hereditary bleeding disorder. The German company in March unveiled plans to spend more than 500 million euros to set up haemophilia drug production sites in Germany, in a sign of confidence in its development pipeline.

Tags: month update drug approval

Category:Chemicals

Latest from this category

All news

05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
04.10RPM General Counsel Edward W. Moore to Retire
04.10AkzoNobel to Review Portfolio with Early Focus on Deco South Asia
03.10AkzoNobel Goes Extra Mile to Help Residents of Worlds Highest Motorable Village
03.10PPG Wins 2024 Supplier Excellence Award from Caterpillar Inc.
02.10RPM Reports Record Fiscal 1Q 2025 Results
02.10Evonik Breaks Ground on Major Silica Expansion at Charleston
01.10BCF CEO Tom Bowtell is Honored for Outstanding Leadership
Chemicals »
05.10Tropical Depression Fourteen Graphics
05.10Tropical Depression Fourteen Forecast Discussion Number 1
05.10Tropical Depression Fourteen Wind Speed Probabilities Number 1
05.10Tropical Depression Fourteen Public Advisory Number 1
05.10Summary for Tropical Depression Fourteen (AT4/AL142024)
05.10Tropical Depression Fourteen Forecast Advisory Number 1
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 25
More »